Literature DB >> 26852144

Development of the Neonatal Intestinal Microbiome and Its Association With Necrotizing Enterocolitis.

Timothy G Elgin1, Stacy L Kern1, Steven J McElroy2.   

Abstract

PURPOSE: Neonatal necrotizing enterocolitis (NEC) remains the most devastating gastrointestinal disease for premature infants. In the United States alone, NEC affects >4000 premature infants yearly, has a mortality rate of nearly 33%, and costs the health care system >$1 billion annually. Although NEC has been actively researched for several decades, its pathophysiology remains elusive. One potential mechanism suggests that disruption of the normal neonatal intestinal bacterial flora induces a proinflammatory state, allowing translocation of pathogens across the intestinal epithelia. Disruption of the normal intestinal flora (dysbiosis) is associated with many human diseases. Thus, it is a reasonable hypothesis that dysbiosis may play an important role in the development of NEC. This hypothesis is supported by evidence that probiotic use in premature infants can prevent the development of NEC. Although the role of probiotics and NEC is covered in other reviews, this review instead focuses on normal bacterial colonization in both term and preterm infants and on the association of dysbiosis and the development of NEC.
METHODS: PubMed was queried with the use of the following key search terms: NEC, neonatal microbiome, fetal microbiome, maternal microbiome, neonatal dysbiosis, and microbiome ontogeny. Relevant literature was reviewed and selected for inclusion in accordance with the objectives of the article according to the authors' discretion. Articles that made key salient points in review articles were further pulled from PubMed.
FINDINGS: Although the onset of NEC is thought to involve bacteria, the mechanisms behind their involvement remain unclear. Research to date has failed to identify a single causative organism, and current theories and data now indicate that a disruption of the host intestinal flora is associated with the onset of disease. Recent reports have found that a bloom of Proteobacteria, specifically Enterobacteriacae species, occurs just before the diagnosis of NEC. Whether this is a causative event or merely a marker of intestinal disease is still unclear. IMPLICATIONS: Because of the complexity of these interactions, it is vital that we continue to investigate the host-bacterial axis in the developing intestine in both humans and in animal models.
Copyright © 2016 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  NEC; development; microbiome; neonate; pathogenesis

Mesh:

Year:  2016        PMID: 26852144     DOI: 10.1016/j.clinthera.2016.01.005

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  38 in total

Review 1.  Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature.

Authors:  Vasilios Pergialiotis; Panagiotis Konstantopoulos; Nikoleta Karampetsou; Diamanto Koutaki; Eleana Gkioka; Despina N Perrea; Nikolaos Papantoniou
Journal:  Inflamm Res       Date:  2016-06-21       Impact factor: 4.575

2.  Lipopolysaccharide-induced maternal inflammation induces direct placental injury without alteration in placental blood flow and induces a secondary fetal intestinal injury that persists into adulthood.

Authors:  Erin M Fricke; Timothy G Elgin; Huiyu Gong; Jeff Reese; Katherine N Gibson-Corley; Robert M Weiss; Kathy Zimmerman; Noelle C Bowdler; Karen M Kalantera; David A Mills; Mark A Underwood; Steven J McElroy
Journal:  Am J Reprod Immunol       Date:  2018-01-25       Impact factor: 3.886

Review 3.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

Review 4.  Recent Advances in Prevention and Therapies for Clinical or Experimental Necrotizing Enterocolitis.

Authors:  Kewei Wang; Guozhong Tao; Karl G Sylvester
Journal:  Dig Dis Sci       Date:  2019-04-15       Impact factor: 3.199

Review 5.  The role of ultrasound in necrotizing enterocolitis.

Authors:  Misun Hwang; Luis O Tierradentro-García; Rebecca A Dennis; Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2021-10-16

6.  Toll-like receptor 4-mediated enteric glia loss is critical for the development of necrotizing enterocolitis.

Authors:  Mark L Kovler; Andres J Gonzalez Salazar; William B Fulton; Peng Lu; Yukihiro Yamaguchi; Qinjie Zhou; Maame Sampah; Asuka Ishiyama; Thomas Prindle; Sanxia Wang; Hongpeng Jia; Peter Wipf; Chhinder P Sodhi; David J Hackam
Journal:  Sci Transl Med       Date:  2021-09-22       Impact factor: 17.956

7.  Butyrate induces development-dependent necrotizing enterocolitis-like intestinal epithelial injury via necroptosis.

Authors:  Kewei Wang; Guo-Zhong Tao; Fereshteh Salimi-Jazi; Po-Yu Lin; Zhen Sun; Bo Liu; Tiffany Sinclair; Mirko Mostaghimi; James Dunn; Karl G Sylvester
Journal:  Pediatr Res       Date:  2022-10-06       Impact factor: 3.953

Review 8.  Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function.

Authors:  Elizabeth C Rose; Jack Odle; Anthony T Blikslager; Amanda L Ziegler
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 6.208

9.  Surgical Versus Medical Management of Necrotizing Enterocolitis With and Without Intestinal Perforation: A Retrospective Chart Review.

Authors:  Muhammad Khalid Syed; Ahmad A Al Faqeeh; Noman Saeed; Talal Almas; Tarek Khedro; Muhammad Ali Niaz; M Ali Kanawati; Salman Hussain; Hussain Mohammad; Lamees Alshaikh; Lina Alshaikh; Abdulaziz Abdulhadi; Abdulaziz Alshamlan; Saifullah Syed; Hamdy Katar Hanafi Mohamed
Journal:  Cureus       Date:  2021-06-17

10.  Developmental intestinal microbiome alterations in canine fading puppy syndrome: a prospective observational study.

Authors:  Smadar Tal; Evgenii Tikhonov; Omry Koren; Sharon Kuzi; Itamar Aroch; Lior Hefetz; Sondra Turjeman
Journal:  NPJ Biofilms Microbiomes       Date:  2021-06-23       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.